Sai-Zhen Zeng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Sai-Zhen Zeng has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Aijun Chen
National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases National Institute for Viral Disease Control and Prevention, China CDC Beijing China
1 shared publication - Chao Wang
National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases National Institute for Viral Disease Control and Prevention, China CDC Beijing China
1 shared publication - Jingdong Song
National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 100052, China
1 shared publication Le Yang
Department of Children's Medical Center, Hunan Provincial People's Hospital and the First Affiliated Hospital of Hunan Normal University, Changsha, China
1 shared publicationLe-Yun Xie
Department of Children's Medical Center, Hunan Provincial People's Hospital and the First Affiliated Hospital of Hunan Normal University, Changsha, China
1 shared publicationLi Peng
Department of Children's Medical Center, Hunan Provincial People's Hospital and the First Affiliated Hospital of Hunan Normal University, Changsha, China
1 shared publication
Latest Publications
- 16 November 2025
- Published by Wiley in Journal of Medical Virology
- Vol. 97 (11) , e70716
Cytopathic Effect and Morphogenesis of WUPyV in Human Airway Epithelial Cells
Washington University polyomavirus (WUPyV), a member of the polyomavirus family capable of infecting the human respiratory tract, exhibits high prevalence in human populations. However, confirmation of its pathogenicity and aetiology has been hindered by challenging culture conditions. To investigate the infective endocytosis of WUPyV, a novel infection model was developed using human airway organoids (HAOs); viral replication dynamics, cell tropism, endocytosis mechanisms, and morphogenesis in human airway epithelium (HAE) were characterized. The results indicated that WUPyV replicates efficiently and infects multiple cell types within the respiratory epithelium. After JC polyomavirus, WUPyV is the second human polyomavirus known to enter cells via clathrin‐mediated endocytosis, independent of caveolar/lipid raft‐mediated endocytosis or macropinocytosis. Consistent with other polyomaviruses, WUPyV is transported to the nucleus for replication and assembly through a lipid‐dependent pathway requiring tyrosine kinase activity and endosome/lysosome acidification. Assembled viral particles were observed in nuclear pores; they were ultimately released extracellularly through vesicles and schistocytes. High‐titre WUPyV infection caused extensive structural damage to the HAE and its cilia. Our findings provide important insights into the endocytosis, morphogenesis, and ultrastructural damage induced by WUPyV, supporting the notion that WUPyV is an underestimated human pathogen.
- 16 November 2025
- Published by Wiley in Journal of Medical Virology
- Vol. 97 (11) , e70716
Cytopathic Effect and Morphogenesis of WUPyV in Human Airway Epithelial Cells
Washington University polyomavirus (WUPyV), a member of the polyomavirus family capable of infecting the human respiratory tract, exhibits high prevalence in human populations. However, confirmation of its pathogenicity and aetiology has been hindered by challenging culture conditions. To investigate the infective endocytosis of WUPyV, a novel infection model was developed using human airway organoids (HAOs); viral replication dynamics, cell tropism, endocytosis mechanisms, and morphogenesis in human airway epithelium (HAE) were characterized. The results indicated that WUPyV replicates efficiently and infects multiple cell types within the respiratory epithelium. After JC polyomavirus, WUPyV is the second human polyomavirus known to enter cells via clathrin‐mediated endocytosis, independent of caveolar/lipid raft‐mediated endocytosis or macropinocytosis. Consistent with other polyomaviruses, WUPyV is transported to the nucleus for replication and assembly through a lipid‐dependent pathway requiring tyrosine kinase activity and endosome/lysosome acidification. Assembled viral particles were observed in nuclear pores; they were ultimately released extracellularly through vesicles and schistocytes. High‐titre WUPyV infection caused extensive structural damage to the HAE and its cilia. Our findings provide important insights into the endocytosis, morphogenesis, and ultrastructural damage induced by WUPyV, supporting the notion that WUPyV is an underestimated human pathogen.
- Open Access
- 1 June 2025
- Published by AME Publishing Company in Translational Pediatrics
- Vol. 14 (6) , 1168-1180
Seasonal epidemiological and clinical characteristics of pediatric patients with respiratory syncytial virus infection by age during COVID-19: a cross-sectional study
Background: To date, reports have been conflicting regarding changes in the age distribution and severity of respiratory syncytial virus (RSV) hospitalizations in children since the beginning of the coronavirus disease 2019 (COVID-19) pandemic. This study aimed to investigate the epidemiological trends and clinical characteristics of RSV infection among children hospitalized with acute lower respiratory tract infection (ALRTI) before and during the COVID-19 pandemic. Methods: A cross-sectional study was conducted from January 2018 to December 2022 in Hunan, China. Data were collected on hospitalized children 14 years or younger with RSV-positive ALRTIs admitted to the Children’s Medical Center of Hunan Provincial People’s Hospital and the First Affiliated Hospital of Hunan Normal University. We evaluated their demographic characteristics, clinical features, and disease severity before and during the COVID-19 pandemic. Results: RSV was detected in 4,255 (17.68%) of the 24,072 children, and the highest detection was 30.90% (1,248 of 4,039) in 2021. The RSV detection rates differed significantly among the years (χ2=664.741, PZ=−12.688, Pvs. 23.61% during the epidemic), and the proportion of children in the 24–59 months old group increased (12.17% before vs. 24.29% during the epidemic) (χ2=92.225, Pvs. 0.89%, χ2=4.178, P=0.04). However, there were no differences in hospitalization duration and the proportion of children admitted to the pediatric intensive care unit (PICU) before and during the COVID-19 epidemic. Conclusions: During the COVID-19 pandemic, RSV-infected children were older and had a lower rate of wheezing and disease severity increased in the age group of under 2 years old.
- 1 June 2025
- Published by AME Publishing Company in Translational Pediatrics
- Vol. 14 (6) , 1168-1180
Open AccessSeasonal epidemiological and clinical characteristics of pediatric patients with respiratory syncytial virus infection by age during COVID-19: a cross-sectional study
Background: To date, reports have been conflicting regarding changes in the age distribution and severity of respiratory syncytial virus (RSV) hospitalizations in children since the beginning of the coronavirus disease 2019 (COVID-19) pandemic. This study aimed to investigate the epidemiological trends and clinical characteristics of RSV infection among children hospitalized with acute lower respiratory tract infection (ALRTI) before and during the COVID-19 pandemic. Methods: A cross-sectional study was conducted from January 2018 to December 2022 in Hunan, China. Data were collected on hospitalized children 14 years or younger with RSV-positive ALRTIs admitted to the Children’s Medical Center of Hunan Provincial People’s Hospital and the First Affiliated Hospital of Hunan Normal University. We evaluated their demographic characteristics, clinical features, and disease severity before and during the COVID-19 pandemic. Results: RSV was detected in 4,255 (17.68%) of the 24,072 children, and the highest detection was 30.90% (1,248 of 4,039) in 2021. The RSV detection rates differed significantly among the years (χ2=664.741, PZ=−12.688, Pvs. 23.61% during the epidemic), and the proportion of children in the 24–59 months old group increased (12.17% before vs. 24.29% during the epidemic) (χ2=92.225, Pvs. 0.89%, χ2=4.178, P=0.04). However, there were no differences in hospitalization duration and the proportion of children admitted to the pediatric intensive care unit (PICU) before and during the COVID-19 epidemic. Conclusions: During the COVID-19 pandemic, RSV-infected children were older and had a lower rate of wheezing and disease severity increased in the age group of under 2 years old.